Search

everythinglearnresearchcommunity

for

Search:↓

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Combining FUE hair transplantation with PRP improves hair density and patient satisfaction in scarring alopecia.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Scarring hair loss found in female pattern; biopsy needed for diagnosis.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Finasteride helps hair growth but may cause sexual side effects and depression.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

In 2017, Spanish dermatologists commonly prescribed topical minoxidil, oral finasteride, and nutricosmetics for hair loss, with oral contraceptives also used for premenopausal women. Less common were oral dutasteride, due to side effects, and newer, more expensive treatments like topical finasteride and Low-Level Laser Therapy. The conclusion is that there's a need for prescription guidelines due to varied treatment approaches.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Trichoscopy is a key method for dermatologists to quickly and effectively diagnose hair and scalp conditions.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.